These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis? Lallemand JY; Stoven V; Annereau JP; Boucher J; Blanquet S; Barthe J; Lenoir G Lancet; 1997 Sep; 350(9079):711-2. PubMed ID: 9291908 [No Abstract] [Full Text] [Related]
12. Cystic fibrosis foundation opens drug discovery lab. Trivedi BP Science; 2016 Sep; 353(6305):1194-5. PubMed ID: 27634505 [No Abstract] [Full Text] [Related]
13. Targeting CFTR: how to treat cystic fibrosis by CFTR-repairing therapies. Amaral MD Curr Drug Targets; 2011 May; 12(5):683-93. PubMed ID: 21039334 [TBL] [Abstract][Full Text] [Related]
14. Cystic Fibrosis: Translating Molecular Mechanisms into Effective Therapies. Jennings MT; Flume PA Ann Am Thorac Soc; 2018 Aug; 15(8):897-902. PubMed ID: 29812963 [TBL] [Abstract][Full Text] [Related]
15. PharmGKB summary: very important pharmacogene information for CFTR. McDonagh EM; Clancy JP; Altman RB; Klein TE Pharmacogenet Genomics; 2015 Mar; 25(3):149-56. PubMed ID: 25514096 [No Abstract] [Full Text] [Related]
16. Cystic fibrosis: five years beyond the gene. Porteous DJ J Inherit Metab Dis; 1995; 18(4):491-4. PubMed ID: 7494406 [No Abstract] [Full Text] [Related]
17. Reshma Kewalramani. Mullard A Nat Rev Drug Discov; 2019 Nov; 18(12):896-897. PubMed ID: 31780855 [No Abstract] [Full Text] [Related]
18. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. Gelman MS; Kopito RR J Clin Invest; 2002 Dec; 110(11):1591-7. PubMed ID: 12464661 [No Abstract] [Full Text] [Related]
19. Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein. Schwiebert EM; Benos DJ; Fuller CM Am J Med; 1998 Jun; 104(6):576-90. PubMed ID: 9674722 [No Abstract] [Full Text] [Related]